Surveillance, CDKN2A and survival of familial melanoma

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):218-219. doi: 10.1111/jdv.18796.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cutaneous Malignant Melanoma
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Genes, p16
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Melanoma* / epidemiology
  • Skin Neoplasms* / epidemiology

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • CDKN2A protein, human